Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study.

Abstract:

BACKGROUND:The purpose of this study was to analyze the extent of hypoxia in prostate carcinoma tumors using the Eppendorf pO(2) microelectrode and correlate this with pretreatment characteristics and prognostic factors. METHODS:Custom-made Eppendorf pO(2) microelectrodes were used to obtain pO(2) measurements from the pathologically involved region of the prostate (as determined by the pretreatment sextant biopsies) as well as from a region of normal muscle for comparison. Each set of measurements comprised approximately 100 separate readings of pO(2), for a total of 10,804 individual measurements. Fifty-five patients with localized prostate carcinoma were studied: Forty-one patients received brachytherapy implants, and 14 patients underwent radical prostatectomy. The pO(2) measurements were obtained in the operating room by using a sterile technique under spinal anesthesia for the brachytherapy group and under general anesthesia for the surgery group. The Eppendorf histograms were recorded and described by the median pO(2), mean pO(2), and percentage < 5 mm Hg and < 10 mm Hg. A multivariate mixed-effects analysis for the prediction of tumor oxygenation was performed and included the following covariates: type of tissue (prostate vs. muscle), type of treatment (implant vs. surgery) and/or anesthesia (spinal vs. general), prostate specific antigen level, disease stage, patient age and race, tumor grade, tumor volume, perineural invasion, and hormonal therapy. RESULTS:Due to differences in patient characteristics and the anesthesia employed, control measurements were obtained from normal muscle (in all but two patients). This internal comparison showed that the oxygen measurements from the pathologically involved portion of the prostate were significantly lower (average median pO(2), 9.9 mm Hg) compared with the measurements normal muscle (average median pO(2), 28.6 mm Hg; P < 0.0001). A multivariate, linear, mixed analysis demonstrated that, among all of the patients, the significant predictors of oxygenation were tissue (prostate vs. muscle) and anesthesia (spinal vs. general) or treatment (implant vs. surgery). Among the brachytherapy (spinal anesthesia) patients, the significant predictors of pO(2) were tissue type, disease stage, and patient age. There were no significant predictors of oxygenation in the surgical (general anesthesia) group. CONCLUSIONS:This study, employing in vivo electrode oxygen measurements, demonstrated that hypoxia exists in prostate carcinoma tumors. A dramatic effect of anesthesia was observed, likely due to modulation of polarography in the presence of fluorine. Within the group of brachytherapy (spinal anesthesia) patients, increasing levels of hypoxia (within prostatic tissue) correlated significantly with increasing clinical stage and patient age. More patients will be accrued to this prospective study to further correlate the oxygenation status in prostate carcinoma tumors with known prognostic factors and, ultimately, treatment outcome.

journal_name

Cancer

journal_title

Cancer

authors

Movsas B,Chapman JD,Greenberg RE,Hanlon AL,Horwitz EM,Pinover WH,Stobbe C,Hanks GE

doi

10.1002/1097-0142(20001101)89:9<2018::aid-cncr19>3

subject

Has Abstract

pub_date

2000-11-01 00:00:00

pages

2018-24

issue

9

eissn

0008-543X

issn

1097-0142

pii

10.1002/1097-0142(20001101)89:9<2018::AID-CNCR19>3

journal_volume

89

pub_type

杂志文章

相关文献

CANCER文献大全
  • Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809.

    abstract:BACKGROUND:Combined transperineal prostate brachytherapy and external beam radiation therapy (EBRT) is widely used for treatment of prostate cancer. Long-term efficacy and toxicity results of a multicenter phase 2 trial assessing combination of EBRT and transperineal prostate brachytherapy boost with androgen deprivati...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26203

    authors: Hurwitz MD,Halabi S,Archer L,McGinnis LS,Kuettel MR,DiBiase SJ,Small EJ

    更新日期:2011-12-15 00:00:00

  • Hypercalcemia in small cell (oat cell) carcinoma of the lung. Coincident parathyroid adenoma in one case.

    abstract::Hypercalcemia is very uncommon in small cell (oat cell) carcinoma of the lung. Two cases of this neoplasm associated with symptomatic hypercalcemia are described. Despite normal skeletal roentgenograms, metastatic bone disease was demonstrated by abnormal bone scans and bone biopsies in both patients. The combination ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197509)36:3<1067::aid-cncr282036

    authors: Bowman DM,Dubé WJ,Levitt M

    更新日期:1975-09-01 00:00:00

  • Racial differences in cervical cancer survival in the Detroit metropolitan area.

    abstract:BACKGROUND:African-American (AA) women have lower survival rates from cervical cancer compared with white women. The objective of this study was to examine the influence of socioeconomic status (SES) and other variables on racial disparities in overall survival among women with invasive cervical cancer. METHODS:One th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23310

    authors: Movva S,Noone AM,Banerjee M,Patel DA,Schwartz K,Yee CL,Simon MS

    更新日期:2008-03-15 00:00:00

  • Survival results in adult patients treated for medulloblastoma.

    abstract::The records of all 27 adult patients (age, greater than or equal to 16 years) diagnosed with cerebellar medulloblastoma between 1968 and 1986 were reviewed. Twenty-four patients (89%) were treated with postoperative megavoltage irradiation. Twenty of these patients underwent craniospinal irradiation. Sixteen patients ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920415)69:8<2143::aid-cncr2820

    authors: Hazuka MB,DeBiose DA,Henderson RH,Kinzie JJ

    更新日期:1992-04-15 00:00:00

  • ThinPrep Pap Test: performance and biopsy follow-up in a university hospital.

    abstract:BACKGROUND:The ThinPrep Pap Test (TP), a liquid-based cervical cytology preparation, was approved for use in the U.S. in 1996. The purpose of this study was to compare TP performance and biopsy follow-up studies with a similar population of high risk patients sampled by conventional Papanicolaou (Pap) smear (CS). METH...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990625)87:3<105::aid-cnc

    authors: Carpenter AB,Davey DD

    更新日期:1999-06-25 00:00:00

  • Racial disparities in cervical cancer survival over time.

    abstract:BACKGROUND:The purpose of this study is to examine changes over time in survival for African American (AA) and white women diagnosed with cervical cancer (CC). METHODS:Surveillance, Epidemiology, and End Results (SEER) Program data from 1985 to 2009 were used for this analysis. Racial differences in survival were eval...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28261

    authors: Rauh-Hain JA,Clemmer JT,Bradford LS,Clark RM,Growdon WB,Goodman A,Boruta DM 2nd,Schorge JO,del Carmen MG

    更新日期:2013-10-15 00:00:00

  • Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia.

    abstract:BACKGROUND:CXC chemokine receptor 4 (CXCR4) is activated by phosphorylation (pCXCR4) and is essential for the migration of hematopoietic precursors to bone marrow. CXCR4 overexpression predicts a poor prognosis in patients with acute myeloid leukemia. Data regarding the prognostic impact of CXCR4 in patients with B-acu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26113

    authors: Konoplev S,Jorgensen JL,Thomas DA,Lin E,Burger J,Kantarjian HM,Andreeff M,Medeiros LJ,Konopleva M

    更新日期:2011-10-15 00:00:00

  • International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988.

    abstract::In 1988, the International Federation of Gynecology and Obstetrics (FIGO) Cancer Committee changed the staging of endometrial carcinoma from a clinical one to a surgicopathologic one. The emphasis in the new FIGO system was changed to the pathologic findings in the uterus, cervix, adnexa, and pelvic and/or periaortic ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.2820710409

    authors: Mikuta JJ

    更新日期:1993-02-15 00:00:00

  • Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.

    abstract:BACKGROUND:In the current study, the authors investigated the incidence of moderate to severe chemotherapy-induced peripheral neuropathy (CIPN) for chemotherapy regimens commonly used in current clinical practice for the treatment of patients with early breast cancer. Patient-reported and clinician-assessed CIPN severi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32175

    authors: Nyrop KA,Deal AM,Reeder-Hayes KE,Shachar SS,Reeve BB,Basch E,Choi SK,Lee JT,Wood WA,Anders CK,Carey LA,Dees EC,Jolly TA,Kimmick GG,Karuturi MS,Reinbolt RE,Speca JC,Muss HB

    更新日期:2019-09-01 00:00:00

  • Pulmonary toxicity of mitomycin.

    abstract::Six patients with breast cancer developed pulmonary toxicity following mitomycin therapy. The presenting symptoms were shortness of breath and a dry cough. The radiological pictures varied from a normal chest x-ray to extensive bilateral pneumonitis. The histological findings consisted of diffuse alveolar damage progr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800115)45:2<236::aid-cncr28204

    authors: Buzdar AU,Legha SS,Luna MA,Tashima CK,Hortobagyi GN,Blumenschein GR

    更新日期:1980-01-15 00:00:00

  • Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use.

    abstract:BACKGROUND:Quantified, human hemoglobin (Hb)-specific, immunochemical fecal occult blood test (IFOBT) measurements are now used for colorectal cancer (CRC) screening. The objective was to evaluate sensitivity and specificity for CRC and advanced adenomatous polyps (APs) by the fecal Hb threshold used to determine a pos...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25012

    authors: Rozen P,Comaneshter D,Levi Z,Hazazi R,Vilkin A,Maoz E,Birkenfeld S,Niv Y

    更新日期:2010-05-01 00:00:00

  • The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.

    abstract:BACKGROUND:Transforming growth factor beta (TGFbeta) is important in colorectal cancer (CRC) progression. Bone morphogenetic proteins (BMPs), a subgroup within the TGFbeta superfamily, recently also have been implicated in CRC, but their precise role in CRC has yet to be investigated. METHODS:The authors used a tissue...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23160

    authors: Kodach LL,Bleuming SA,Musler AR,Peppelenbosch MP,Hommes DW,van den Brink GR,van Noesel CJ,Offerhaus GJ,Hardwick JC

    更新日期:2008-01-15 00:00:00

  • High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.

    abstract:BACKGROUND:In a previous study of gene array data, the authors identified survivin as a candidate marker of aggressiveness in clear cell renal cell carcinoma (ccRCC). What remained in question was whether survivin expression at the protein level is an independent predictor of disease progression and cancer-specific sur...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21952

    authors: Parker AS,Kosari F,Lohse CM,Houston Thompson R,Kwon ED,Murphy L,Riehle DL,Blute ML,Leibovich BC,Vasmatzis G,Cheville JC

    更新日期:2006-07-01 00:00:00

  • Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx.

    abstract:BACKGROUND:An association between laryngopharyngeal reflux (LPR) and laryngeal carcinoma has been suggested, but remains unproven. The current pilot study was performed to determine the incidence of LPR among patients with early laryngeal carcinomas or dysplasia and to examine the associations between levels of LPR and...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11158

    authors: Lewin JS,Gillenwater AM,Garrett JD,Bishop-Leone JK,Nguyen DD,Callender DL,Ayers GD,Myers JN

    更新日期:2003-02-15 00:00:00

  • Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer.

    abstract:BACKGROUND:Previous reports based on small patient numbers suggested that changes in serum HER-2/neu levels may predict response or lack of response to trastuzumab-based therapies in metastatic breast cancer (MBC). The objectives of this study were to pool data from 307 patients with MBC from 7 medical institutions to ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.23689

    authors: Ali SM,Carney WP,Esteva FJ,Fornier M,Harris L,Köstler WJ,Lotz JP,Luftner D,Pichon MF,Lipton A,Serum HER-2\/neu Study Group.

    更新日期:2008-09-15 00:00:00

  • The impact of age, treatment, and symptoms on the physical and mental health of cancer patients. A longitudinal perspective.

    abstract:BACKGROUND:To describe continuing care and rehabilitation needs of cancer patients, a longitudinal design (6 months) was performed among patients 50 years of age and older with solid tumors. The study examined how age, type of treatment, site of cancer, and symptom experience affect physical functioning and their menta...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19941001)74:7+<2128::aid-cncr282

    authors: Given CW,Given BA,Stommel M

    更新日期:1994-10-01 00:00:00

  • Humoral hypercalcemia in patients with colorectal carcinoma: report of two cases and review of the literature.

    abstract:BACKGROUND:Humoral hypercalcemia rarely is associated with colorectal carcinoma; to the authors' knowledge only nine cases have been reported to date. METHODS:Two cases of advanced colorectal carcinoma with humoral hypercalcemia of malignancy (HHM) are presented. RESULTS:The two patients had severe hypercalcemia with...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Lortholary AH,Cadeau SD,Bertrand GM,Guerin-Meyer VI,Gamelin EC,Audran MJ

    更新日期:1999-12-01 00:00:00

  • Oncologic imaging. Staging and follow-up of renal and adrenal carcinoma.

    abstract::Computed tomography (CT) has emerged from the 1980s to play a dominant role in the pretreatment staging of renal and adrenal carcinomas. For detection, definition (staging), and determination of resectability or recurrence, CT with intravenous contrast enhancement, and more recently, magnetic resonance imaging (MRI) w...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19910215)67:4+<1199::aid-cncr282

    authors: McClennan BL

    更新日期:1991-02-15 00:00:00

  • Comparability of prostate trials.

    abstract::The present overview of advanced prostate cancer required the identification of randomized clinical trials studying the question of maximal androgen blockade versus the classic castration therapy. The heterogeneity of the trials concerned the type of castration (surgical or chemical) and the type of antiandrogen (flut...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19931215)72:12+<3841::aid-cncr28

    authors: Suciu S,Sylvester R,Iversen P,Christensen I,Denis L

    更新日期:1993-12-15 00:00:00

  • The Breast and Cervical Cancer Early Detection Program, Medicaid, and breast cancer outcomes among Ohio's underserved women.

    abstract:BACKGROUND:As an organized screening program, the national Breast and Cervical Cancer Early Detection Program (BCCEDP) was launched in the early 1990s to improve breast cancer outcomes among underserved women. To analyze the impact of the BCCEDP on breast cancer outcomes in Ohio, this study compared cancer stages and m...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30720

    authors: Koroukian SM,Bakaki PM,Htoo PT,Han X,Schluchter M,Owusu C,Cooper GS,Rose J,Flocke SA

    更新日期:2017-08-15 00:00:00

  • The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.

    abstract::Over the last decade, new cytotoxic treatments and targeted therapies have altered treatment paradigms for patients with metastatic non-small cell lung cancer (NSCLC). We sought to analyze the impact of histology and biomarker selection criteria on outcomes of clinical trials in metastatic NSCLC reported over the last...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28956

    authors: Gentzler RD,Yentz SE,Johnson ML,Rademaker AW,Patel JD

    更新日期:2014-12-15 00:00:00

  • Intensive systemic chemotherapy in localized Ewing's sarcoma in childhood. A historical trial.

    abstract::To assess the value in Ewing's sarcoma of a new multiagent therapy (vincristine, cyclophosphamide, Adriamycin, (doxorubicin) procarbazine), 30 children with a localized tumor (eight distal, nine proximal, 13 central lesions) treated at the Institut Gustave-Roussy between 1973 and 1976 (E3), were pair-matched by site o...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19830801)52:3<415::aid-cncr28205

    authors: Zucker JM,Henry-Amar M,Sarrazin D,Blache R,Patte C,Schweisguth O

    更新日期:1983-08-01 00:00:00

  • Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.

    abstract:BACKGROUND:Several studies have demonstrated that abnormal levels of nuclear matrix protein 22 (NMP22) are associated with bladder cancer and have led to the approval of NMP22 as a urinary biomarker by the US Food and Drug Administration. Nonetheless, the clinical significance of NMP22 remains unclear. The objective of...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.25903

    authors: Shariat SF,Savage C,Chromecki TF,Sun M,Scherr DS,Lee RK,Lughezzani G,Remzi M,Marberger MJ,Karakiewicz PI,Vickers AJ

    更新日期:2011-07-01 00:00:00

  • Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.

    abstract:BACKGROUND:This study examined the influence of prior treatment on the course of cognitive functioning in breast cancer survivors. Changes in cognitive functioning over time were compared in breast cancer survivors treated with chemotherapy plus radiotherapy, breast cancer survivors treated with radiotherapy only, and ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26432

    authors: Phillips KM,Jim HS,Small BJ,Laronga C,Andrykowski MA,Jacobsen PB

    更新日期:2012-04-01 00:00:00

  • Acute megakaryoblastic leukemia in childhood.

    abstract::Routine morphologic and cytochemical study of the leukemic cells of a 13-month-old child did not permit definitive determination of either a lymphoid or a myeloid cell origin. However, ultrastructural cytochemical analysis revealed platelet peroxidase (PPO) reactivity. The malignant cells expressed PPO in both unfixed...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841001)54:7<1423::aid-cncr2820

    authors: Sariban E,Oliver C,Corash L,Cossman J,Whang-Peng J,Jaffe ES,Gralnick HR,Poplack DG

    更新日期:1984-10-01 00:00:00

  • Prophylactic cranial irradiation in limited-stage small cell lung cancer.

    abstract:BACKGROUND:The role of prophylactic cranial irradiation (PCI) for patients with limited-stage small cell lung cancer (LSSCLC) remains a controversial issue. This study evaluated PCI in patients with LSSCLC who achieved a complete response to initial chemotherapy. METHODS:A retrospective case study of all nonprotocol p...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950315)75:6<1302::aid-cncr2820

    authors: Liengswangwong V,Bonner JA,Shaw EG,Foote RL,Frytak S,Richardson RL,Creagan ET,Eagan RT,Su JQ

    更新日期:1995-03-15 00:00:00

  • Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia.

    abstract::In patients with chronic myeloid leukemia (CML), the hallmark Philadelphia chromosome is the marker of disease that can be detected by conventional metaphase cytogenetics, fluorescence in situ hybridization, or polymerase chain reaction. The current "gold standard" of treatment response is cytogenetic response. Cytoge...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.26280

    authors: Radich JP

    更新日期:2012-01-15 00:00:00

  • Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.

    abstract:BACKGROUND:A clinicopathologic evaluation of clinical Stage I and II uterine sarcoma was done by the Gynecologic Oncology Group from 1979-1988. METHODS:After all eligibility criteria were met, 453 cases were evaluable and analyzed for prognostic factors. RESULTS:Of the 301 mixed mesodermal tumors (MMT), 167 were homo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.2820710440

    authors: Major FJ,Blessing JA,Silverberg SG,Morrow CP,Creasman WT,Currie JL,Yordan E,Brady MF

    更新日期:1993-02-15 00:00:00

  • Gangliosides of human melanoma.

    abstract::Human melanoma synthesizes a large quantity of gangliosides, glycosphingolipids containing sialic acid. The authors previously have demonstrated that the ganglioside profile differs among individual melanomas and is widely heterogeneous. In the current study, a retrospective study was performed to compare the relation...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890315)63:6<1166::aid-cncr2820

    authors: Tsuchida T,Saxton RE,Morton DL,Irie RF

    更新日期:1989-03-15 00:00:00

  • Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).

    abstract:BACKGROUND:The effect of adjuvant chemotherapy after resection of nonsmall cell lung cancer (NSCLC) remains an unresolved question. METHODS:From October, 1982, to November, 1986, 267 patients with resected NSCLC were included in a randomized trial. The adjuvant allocated treatments were either postoperative radiothera...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19950901)76:5<779::aid-cncr28207

    authors: Dautzenberg B,Chastang C,Arriagada R,Le Chevalier T,Belpomme D,Hurdebourcq M,Lebeau B,Fabre C,Charvolin P,Guérin RA

    更新日期:1995-09-01 00:00:00